SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-004229
Filing Date
2022-02-08
Accepted
2022-02-08 16:01:21
Documents
13
Period of Report
2022-02-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K scyx-8k_20220204.htm   iXBRL 8-K 48650
2 EX-10.1 scyx-ex101_7.htm EX-10.1 70863
  Complete submission text file 0001564590-22-004229.txt   265136

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA scyx-20220204.xsd EX-101.SCH 5937
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20220204_lab.xml EX-101.LAB 19843
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20220204_pre.xml EX-101.PRE 12355
7 EXTRACTED XBRL INSTANCE DOCUMENT scyx-8k_20220204_htm.xml XML 3540
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 22601535
SIC: 2834 Pharmaceutical Preparations